Motor performance and functionality improvements were seen, with a lower disability score observed in the intranasal insulin group compared to baseline scores, suggesting that intranasal insulin may be a feasible treatment for PD
July 30, 2024: Study Links Active Ingredient in Some GLP-1 Drugs to Vision Loss June 17, 2024: Mounjaro Lawsuit Advances with First Status Conference Under New Judge Karen Marston June 9, 2024: Judge Karen Spence Marston to Preside Over Mounjaro Lawsuit May 20, 2024: Judge Change in Mounjaro Lawsuit Following Judge Pratters Death May 2, 2024: Mounjaro Lawsuit Science Day Scheduled for June 14, 2024 April 25, 2024: Mounjaro Lawsuit Initiated with Plaintiffs First Statement of the Case April 20, 2024: Mounjaro Lawsuits Still in Early Stages Mounjaro Lawsuits Still in Early Stages To date, the lawsuits against the maker of Mounjaro are still in the early stages of litigation
If these dont match what youre looking for, youre probably better off choosing a different GLP-1 provider
Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention
Just enough to have something in the stomach
Yes, absolutely
